In this study, we used an Ibidi cell culture insert and live-cell tracking routines to evaluate the migratory properties of MDA-MB-231 breast cancer cells with shRNA-mediated knockdown of MYOF and cells treated with a lentiviral non-human, non-targeting control vector. This evidence concerns the gene MYOF and breast cancer.